Nucleoside derivatives for treatment of Caliciviridae infections, including Norovirus infections
US8415321B2 · kind B2 · utility
25Cited by
3References
21Claims
0Family size
Inventors
Key dates
| Filing date | Apr 9, 2009 |
| Grant date | Apr 9, 2013 |
| Priority date | — |
| Expiry date | Mar 7, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method and composition for treating a host infected with a Caliciviridae virus, such as a Norovirus, comprising administering an effective treatment amount of a described modified nucleoside or a pharmaceutically acceptable salt thereof, is provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.